Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial

Masahiro Takeyama, Kenichi Ogiwara, Naoki Ozu, Kana Sasai, Masato Kasahara, Yasuko Furuichi, Toshio Takase, Iyou Nakagawa, Katsuyuki Fukutake, Akira Ishiguro, Kagehiro Amano, Eisuke Adachi, Kumiko Ono, Chiai Nagae, Atsuki Yamashita, Satoshi Higasa, Teruhisa Fujii, Masanori Matsumoto, Midori Shima, Keiji Nogami

Open source

DOI: 10.1016/j.rpth.2026.106849
Published: 2026-07
Container: Research and Practice in Thrombosis and Haemostasis
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.rpth.2026.106849,
  title = {Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial},
  author = {Masahiro Takeyama and Kenichi Ogiwara and Naoki Ozu and Kana Sasai and Masato Kasahara and Yasuko Furuichi and Toshio Takase and Iyou Nakagawa and Katsuyuki Fukutake and Akira Ishiguro and Kagehiro Amano and Eisuke Adachi and Kumiko Ono and Chiai Nagae and Atsuki Yamashita and Satoshi Higasa and Teruhisa Fujii and Masanori Matsumoto and Midori Shima and Keiji Nogami},
  year = {2026},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  doi = {10.1016/j.rpth.2026.106849},
  url = {https://doi.org/10.1016/j.rpth.2026.106849}
}

RIS

TY  - JOUR
TI  - Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial
AU  - Masahiro Takeyama
AU  - Kenichi Ogiwara
AU  - Naoki Ozu
AU  - Kana Sasai
AU  - Masato Kasahara
AU  - Yasuko Furuichi
AU  - Toshio Takase
AU  - Iyou Nakagawa
AU  - Katsuyuki Fukutake
AU  - Akira Ishiguro
AU  - Kagehiro Amano
AU  - Eisuke Adachi
AU  - Kumiko Ono
AU  - Chiai Nagae
AU  - Atsuki Yamashita
AU  - Satoshi Higasa
AU  - Teruhisa Fujii
AU  - Masanori Matsumoto
AU  - Midori Shima
AU  - Keiji Nogami
PY  - 2026
JO  - Research and Practice in Thrombosis and Haemostasis
DO  - 10.1016/j.rpth.2026.106849
UR  - https://doi.org/10.1016/j.rpth.2026.106849
ER  -

APA

Takeyama, M., Ogiwara, K., Ozu, N., Sasai, K., Kasahara, M., Furuichi, Y., Takase, T., Nakagawa, I., Fukutake, K., Ishiguro, A., Amano, K., Adachi, E., Ono, K., Nagae, C., Yamashita, A., Higasa, S., Fujii, T., Matsumoto, M., Shima, M., & Nogami, K. (2026). Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2026.106849

Source records

crossref · retrieved 2026-09-26T17:13:33.869Z